
S.87. A Phase-II Clinical Trial of Rituximab Therapy after Allogeneic HCT: Decreased Alloreactive B cells Responses and Chronic GVHD Incidence
Bita Sahaf, Sally Arai, George Chen, Kartoosh Heydari, Julie Boiko, David MiklosVolume:
131
Année:
2009
Langue:
english
Pages:
1
DOI:
10.1016/j.clim.2009.03.461
Fichier:
PDF, 37 KB
english, 2009